Modern aspects of the therapy of acute respiratory viral infections (systematic review)
The emergence of new strains of respiratory viruses, especially pandemic ones, resistant to antiviral drugs, dictates the need for further search for new molecules, or reformatting of existing drugs, expanding their indications for use. The use of broadspectrum antivirals or immunomodulators is now...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2024-12-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The emergence of new strains of respiratory viruses, especially pandemic ones, resistant to antiviral drugs, dictates the need for further search for new molecules, or reformatting of existing drugs, expanding their indications for use. The use of broadspectrum antivirals or immunomodulators is now well justified. The goal is to systematize published data on the effectiveness and safety of the drug inosine pranobex for acute respiratory viral infections, including influenza and the new coronavirus infection COVID19. The results of in vivo and in vitro studies are summarized, which examine the mechanisms of influence of inosine pranobex on the human immune system and therapeutic effectiveness against a wide range of viral pathogens. The positive results of clinical studies conducted in different countries on ARVI and influenza are briefly described. A promising direction is the use of inosine pranobex in the treatment of COVID19, which has been proven by its use in clinical trials in adults by researchers from different countries and is reflected in our review. |
|---|---|
| ISSN: | 2072-6732 |